Overview

The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis

Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the effect of the GLP-1 analogue Victoza® on psoriasis in a double-blinded, randomized placebo-controlled clinical trial.
Phase:
N/A
Details
Lead Sponsor:
Annesofie Faurschou
Collaborator:
University of Copenhagen
Treatments:
Liraglutide